ArticleJournal of thrombosis and haemostasis : JTH2022

Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa.

Stefan Heitmeier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.